Mutation study in Covid-19
Not Applicable
- Conditions
- Health Condition 1: U07-U07- Provisional assignment of new diseases of uncertain etiology or emergency use
- Registration Number
- CTRI/2021/10/037034
- Lead Sponsor
- Cancyte Technologies Private Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All the Covid-19 positive samples collected at Cancyte for the period of Jan 2021-July 2021
Exclusion Criteria
NA
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Detecting presence of Covid-19 delta variants by RT-PCR in the samples collected by Nasopharyngeal and Oropharyngeal swabs preserved at our library.Timepoint: 01 week
- Secondary Outcome Measures
Name Time Method Establishing a rapid and reliable detection of the delta mutants in an ICMR approved PCR labsTimepoint: 01 Week